Finland Regional Leadership and Cerner Collaborate on Vision for Integrated Health and Care
September 10 2020 - 9:00AM
Cerner Corporation (Nasdaq: CERN), a global health care technology
company, announced a collaboration with Finland regional leadership
that is expected to deliver more coordinated and efficient access
to health and social services through a government-sponsored set of
standards. This announcement comes at a time when Finland is
undergoing a transformation to shift responsibility for the
organization of health and social services from municipal based
health and social care to combined regional authorities.
Aster, a co-operational organization across four of Finland’s
nineteen regions; including Central Finland, Ostrobothnia, South
Savo and North Karelia; is actively working to establish the new
health care and social services system. The co-designed digital
platform will support the delivery of an enhanced, streamlined
approach to the provision of health and social services, providing
citizens with access to integrated outpatient and inpatient care,
behavioral health services, services for families with children,
dental and more.
The project will be executed in two phases: the first phase
focused on development and planning over a one-year period. Subject
to the parties’ agreement of a shared plan, Cerner plans to
contract with Aster to deliver the second phase, in which the
technology is delivered and implemented.
As part of this effort, approximately 15,000 clinicians and
10,000 social service workers will receive additional support to
address the unique needs of an evolving integrated health and
social welfare system. Aster seeks to increase transparency between
social and health care organizations, give experts better
visibility into population data in one system and empower citizens
to access their holistic and aggregated information.
“As these four districts come together to build a new model of
health care and social services for our citizens, we needed a
leading technology partner with local experience and presence that
could integrate care across boundaries and populations. With
Cerner’s expertise in health technology, along with the company’s
experience in the international and Nordic markets, we are
confident this decision will support our mission,” said Simo
Reipas, director, Aster. “Our 25,000 clinical and social staff work
very hard to take excellent care of our citizens. As we transform
our care delivery model, it’s our duty to equip our staff with the
advanced technology, like Cerner®, designed to support their
ability to deliver care and social services and enable our citizens
to participate in their own services.”
“Finland’s government is undergoing remarkable transformation
intended to enhance how health and social care is delivered to its
constituents. Cerner is honored to be selected as the technology to
support this renowned journey and looks forward to working with
Aster on architecting the visionary integrated platform for care,”
said Emil Peters, president, Cerner Global. “Aster provides a vast
array of care to its communities and we believe Cerner’s technology
will provide a coordinated and organized care team approach, with
care encounters now connected throughout patients’ health and
social care journey. Other government entities will benefit from
the precedent Aster is setting.”
About CernerCerner’s health technologies
connect people and information systems in thousands of contracted
provider facilities worldwide dedicated to creating smarter and
better care for individuals and communities. Recognized globally
for innovation, Cerner assists clinicians in making care decisions
and assists organizations in managing the health of their
populations. The company also offers an integrated clinical and
financial system to help manage day-to-day revenue functions, as
well as a wide range of services to support clinical, financial and
operational needs, focused on people. For more information,
visit Cerner.com, The Cerner Blog or connect
on Facebook, Instagram, LinkedIn, Twitter or The
Cerner Podcast. Nasdaq: CERN. Health care is too
important to stay the same.
Media Contacts:CernerStephanie
Greenwood, Media Relations, Stephanie.Greenwood@cerner.com
All statements in this press release that do not directly and
exclusively relate to historical facts constitute forward-looking
statements. These forward-looking statements are based on the
current beliefs, expectations and assumptions of Cerner's
management with respect to future events and are subject to a
number of significant risks and uncertainties. It is
important to note that Cerner's performance, and actual results,
financial condition or business could differ materially from those
expressed in such forward-looking statements. The words “expects”,
“believe”, or the negative of these words, variations thereof or
similar expressions are intended to identify such forward-looking
statements. For example, our forward-looking statements include
statements regarding the future benefits or synergies of the
collaboration and the agreement on final terms of a shared plan.
Factors that could cause or contribute to such differences
include, but are not limited to: the possibility of significant
costs and reputational harm related to product and service-related
liabilities; potential claims for system errors and warranties; the
possibility of interruption at our data centers or client support
facilities, or those of third parties with whom we have contracted
(such as public cloud providers), that could expose us to
significant costs and reputational harm; the possibility of
increased expenses, exposure to legal claims and regulatory actions
and reputational harm associated with a cyberattack or other breach
in our IT security or the IT security of third parties on which we
rely; our proprietary technology may be subject to claims for
infringement or misappropriation of intellectual property rights of
others, or may be infringed or misappropriated by others or subject
to claims related to open source licenses; material adverse
resolution of legal proceedings or other claims or reputational
harm stemming from negative publicity related to such claims or
legal proceedings; risks associated with our global operations; the
uncertainty surrounding the impact of the departure of the United
Kingdom from the European Union on our global business; risks
associated with the unexpected loss or recruitment and retention of
key personnel or the failure to successfully develop and execute
succession planning to assure transitions of key associates and
their knowledge, relationships and expertise; risks related to our
dependence on strategic relationships and third party suppliers,
including any impact to the business of such suppliers resulting
from the COVID-19 pandemic; risks associated with volatility and
disruption resulting from global economic or market conditions,
including any impact thereon resulting from events such as the
COVID-19 pandemic; significant competition and our ability to
anticipate or respond quickly to market changes, changing
technologies and evolving pricing and deployment methods and to
bring competitive new solutions, devices, features and services to
market in a timely fashion; managing growth in the new markets in
which we offer solutions, health care devices or services; long
sales cycles for our solutions and services; risks inherent in
contracting with government clients, including without limitation,
complying with strict compliance and disclosure obligations,
navigating complex procurement rules and processes and defending
against bid protests; changing political, economic, regulatory and
judicial influences, which could impact the purchasing practices
and operations of our clients and increase costs to deliver
compliant solutions and services; non-compliance with laws,
government regulations or certain industry initiatives or failure
to deliver solutions or services that enable our clients to comply
with laws or regulations applicable to their businesses; the extent
to which the COVID-19 pandemic and measures taken in response
thereto could adversely affect our financial condition, future
bookings and results of operations, including risks associated with
the impact of the COVID-19 pandemic on collecting accounts
receivable; and, failure of the parties to achieve the intended
benefits of the collaboration.. Additional discussion of these and
other risks, uncertainties and factors affecting Cerner's business
is contained in Cerner's filings with the Securities and Exchange
Commission. The reader should not place undue reliance on
forward-looking statements, since the statements speak only as of
the date that they are made. Except as required by law, Cerner
undertakes no obligation to update or revise forward-looking
statements to reflect changed assumptions, the occurrence of
unanticipated events, or changes in our business, results of
operations or financial condition over time.
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Apr 2023 to Apr 2024